Literature DB >> 23641296

Fourth Asian PAD Workshop.

.   

Abstract

Year:  2013        PMID： 23641296      PMCID： PMC3635012          DOI： 10.3400/avd.pad.12.01000

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN： 1881-641X


× No keyword cloud information.
  51 in total

1.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

Authors:  Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

Review 2.  Lower extremity arterial reconstruction in patients with diabetes mellitus.

Authors:  J M Estes; F B Pomposelli
Journal:  Diabet Med       Date:  1996       Impact factor: 4.359

3.  A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.

Authors:  Reena L Pande; William R Hiatt; Peter Zhang; Norbert Hittel; Mark A Creager
Journal:  Vasc Med       Date:  2010-04-12       Impact factor: 3.239

4.  Peripheral arterial disease in the elderly: The Rotterdam Study.

Authors:  W T Meijer; A W Hoes; D Rutgers; M L Bots; A Hofman; D E Grobbee
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

5.  Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.

Authors:  M Lièvre; S Morand; B Besse; J N Fiessinger; J P Boissel
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways.

Authors:  Kazuo Niwano; Masashi Arai; Koichi Tomaru; Tsuyoshi Uchiyama; Yoshio Ohyama; Masahiko Kurabayashi
Journal:  Circ Res       Date:  2003-08-14       Impact factor: 17.367

8.  Prevalence and risk factors of peripheral arterial disease in a selected Thai population.

Authors:  Piyamitr Sritara; Chanika Sritara; Mark Woodward; Somjai Wangsuphachart; Federica Barzi; Bunlue Hengprasith; Tada Yipintsoi
Journal:  Angiology       Date:  2007 Oct-Nov       Impact factor: 3.619

9.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

10.  Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Authors:  Jeffrey S Berger; Mori J Krantz; John M Kittelson; William R Hiatt
Journal:  JAMA       Date:  2009-05-13       Impact factor: 56.272
View more
  1 in total

1.  Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

Authors:  Jayesh Dalpatbhai Solanki; Amit H Makwana; Hemant B Mehta; Pradnya A Gokhale; Chinmay J Shah
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.